APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pramipexole Hydrochloride Extended Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pramipexole Hydrochloride Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025185 pages

Choose your research edition.

Industry ResearchPramipexole Hydrochloride Extended Release Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pramipexole Hydrochloride Extended Release Tablets Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Pramipexole Hydrochloride Extended Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pramipexole Hydrochloride Extended Release Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pramipexole Hydrochloride Extended Release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pramipexole Hydrochloride Extended Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pramipexole Hydrochloride Extended Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pramipexole Hydrochloride Extended Release Tablets include Tianjin Chasesun Pharmaceutical, Qilu Pharmaceutical (Hainan), Zhejiang Jingxin Pharmaceutical, Xiamen LP Pharmaceutical, Macleods Pharmaceuticals Ltd, Cspc Ouyi Pharmaceutical and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pramipexole Hydrochloride Extended Release Tablets market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pramipexole Hydrochloride Extended Release Tablets and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pramipexole Hydrochloride Extended Release Tablets revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pramipexole Hydrochloride Extended Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Pramipexole Hydrochloride Extended Release Tablets Segment by Company

Tianjin Chasesun Pharmaceutical

Qilu Pharmaceutical (Hainan)

Zhejiang Jingxin Pharmaceutical

Xiamen LP Pharmaceutical

Macleods Pharmaceuticals Ltd

Cspc Ouyi Pharmaceutical

Boehringer Ingelheim International GmbH

Pramipexole Hydrochloride Extended Release Tablets Segment by Type

0.75mg

1.5mg

3.0mg

4.5mg

Others

Pramipexole Hydrochloride Extended Release Tablets Segment by Application

Hospital

Clinic

Others

Pramipexole Hydrochloride Extended Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pramipexole Hydrochloride Extended Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pramipexole Hydrochloride Extended Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pramipexole Hydrochloride Extended Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pramipexole Hydrochloride Extended Release Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pramipexole Hydrochloride Extended Release Tablets industry.

Chapter 3: Detailed analysis of Pramipexole Hydrochloride Extended Release Tablets companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pramipexole Hydrochloride Extended Release Tabletsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 0.75mg Table 3. Key Players of 1.5mg Table 4. Key Players of 3.0mg Table 3. Key Players of 4.5mg Table 4. Key Players of Others Table 5. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Clinic Table 8. Key Players of Others Table 9. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region (2021-2026) Table 12. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region (2027-2032) Table 14. Pramipexole Hydrochloride Extended Release Tablets Industry Trends Table 15. Pramipexole Hydrochloride Extended Release Tablets Industry Drivers Table 16. Pramipexole Hydrochloride Extended Release Tablets Industry Opportunities and Challenges Table 17. Pramipexole Hydrochloride Extended Release Tablets Industry Restraints Table 18. Global Pramipexole Hydrochloride Extended Release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Company (2021-2026) Table 20. Global Pramipexole Hydrochloride Extended Release Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pramipexole Hydrochloride Extended Release Tablets Key Company Head Office and Area Served Table 22. Global Pramipexole Hydrochloride Extended Release Tablets Company, Product Type & Application Table 23. Global Pramipexole Hydrochloride Extended Release Tablets Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pramipexole Hydrochloride Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Type (2021-2026) Table 30. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Type (2027-2032) Table 31. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Application (2021-2026) Table 35. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Application (2027-2032) Table 36. Tianjin Chasesun Pharmaceutical Company Information Table 37. Tianjin Chasesun Pharmaceutical Business Overview Table 38. Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 40. Tianjin Chasesun Pharmaceutical Recent Development Table 41. Qilu Pharmaceutical (Hainan) Company Information Table 42. Qilu Pharmaceutical (Hainan) Business Overview Table 43. Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 45. Qilu Pharmaceutical (Hainan) Recent Development Table 46. Zhejiang Jingxin Pharmaceutical Company Information Table 47. Zhejiang Jingxin Pharmaceutical Business Overview Table 48. Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 50. Zhejiang Jingxin Pharmaceutical Recent Development Table 51. Xiamen LP Pharmaceutical Company Information Table 52. Xiamen LP Pharmaceutical Business Overview Table 53. Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 55. Xiamen LP Pharmaceutical Recent Development Table 56. Macleods Pharmaceuticals Ltd Company Information Table 57. Macleods Pharmaceuticals Ltd Business Overview Table 58. Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 60. Macleods Pharmaceuticals Ltd Recent Development Table 61. Cspc Ouyi Pharmaceutical Company Information Table 62. Cspc Ouyi Pharmaceutical Business Overview Table 63. Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 65. Cspc Ouyi Pharmaceutical Recent Development Table 66. Boehringer Ingelheim International GmbH Company Information Table 67. Boehringer Ingelheim International GmbH Business Overview Table 68. Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Product Portfolio Table 70. Boehringer Ingelheim International GmbH Recent Development Table 71. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 72. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 73. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 74. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 75. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) Table 77. North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032) Table 78. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 79. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 80. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 81. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 82. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) Table 84. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032) Table 85. China Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 86. China Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 87. China Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 88. China Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 89. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 90. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 91. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 92. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) Table 95. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032) Table 96. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 97. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032) & (US$ Million) Table 98. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026) Table 102. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Pramipexole Hydrochloride Extended Release Tablets Product Image Figure 2. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Type: 2025 VS 2032 Figure 4. 0.75mg Image Figure 5. 1.5mg Image Figure 6. 3.0mg Image Figure 7. 4.5mg Image Figure 8. Others Image Figure 9. Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Pramipexole Hydrochloride Extended Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 16. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pramipexole Hydrochloride Extended Release Tablets Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pramipexole Hydrochloride Extended Release Tablets Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Type (2021-2032) Figure 23. Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pramipexole Hydrochloride Extended Release Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 26. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032) Figure 27. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032) Figure 28. North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 29. United States Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032) Figure 34. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032) Figure 35. Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 36. Germany Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 37. France Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 42. China Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 43. China Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032) Figure 44. China Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032) Figure 45. Asia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032) Figure 47. Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032) Figure 48. Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 49. Japan Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 53. India Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032) Figure 59. Brazil Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • 0.75mg
  • 1.5mg
  • 3.0mg
  • 4.5mg
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Tianjin Chasesun Pharmaceutical
  • Qilu Pharmaceutical (Hainan)
  • Zhejiang Jingxin Pharmaceutical
  • Xiamen LP Pharmaceutical
  • Macleods Pharmaceuticals Ltd
  • Cspc Ouyi Pharmaceutical
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 0.75mg
  5. 1.2.3 1.5mg
  6. 1.2.4 3.0mg
  7. 1.2.5 4.5mg
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pramipexole Hydrochloride Extended Release Tablets Growth Trends by Region
  16. 1.5.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2021-2026)
  18. 1.5.3 Pramipexole Hydrochloride Extended Release Tablets Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pramipexole Hydrochloride Extended Release Tablets Market Dynamics
  1. 2.1 Pramipexole Hydrochloride Extended Release Tablets Industry Trends
  2. 2.2 Pramipexole Hydrochloride Extended Release Tablets Industry Drivers
  3. 2.3 Pramipexole Hydrochloride Extended Release Tablets Industry Opportunities and Challenges
  4. 2.4 Pramipexole Hydrochloride Extended Release Tablets Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pramipexole Hydrochloride Extended Release Tablets Revenue by Company (2021-2026)
  2. 3.2 Global Pramipexole Hydrochloride Extended Release Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pramipexole Hydrochloride Extended Release Tablets Key Company Head office and Area Served
  4. 3.4 Global Pramipexole Hydrochloride Extended Release Tablets Company, Product Type & Application
  5. 3.5 Global Pramipexole Hydrochloride Extended Release Tablets Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pramipexole Hydrochloride Extended Release Tablets Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pramipexole Hydrochloride Extended Release Tablets Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pramipexole Hydrochloride Extended Release Tablets Tier 1, Tier 2, and Tier 3
4 Pramipexole Hydrochloride Extended Release Tablets Market by Type
  1. 4.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2032)
  3. 4.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Type (2021-2032)
5 Pramipexole Hydrochloride Extended Release Tablets Market by Application
  1. 5.1 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2032)
  3. 5.3 Global Pramipexole Hydrochloride Extended Release Tablets Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Tianjin Chasesun Pharmaceutical
  2. 6.1.1 Tianjin Chasesun Pharmaceutical Company Information
  3. 6.1.2 Tianjin Chasesun Pharmaceutical Business Overview
  4. 6.1.3 Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Tianjin Chasesun Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  6. 6.1.5 Tianjin Chasesun Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical (Hainan)
  8. 6.2.1 Qilu Pharmaceutical (Hainan) Company Information
  9. 6.2.2 Qilu Pharmaceutical (Hainan) Business Overview
  10. 6.2.3 Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical (Hainan) Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical (Hainan) Recent Developments
  13. 6.3 Zhejiang Jingxin Pharmaceutical
  14. 6.3.1 Zhejiang Jingxin Pharmaceutical Company Information
  15. 6.3.2 Zhejiang Jingxin Pharmaceutical Business Overview
  16. 6.3.3 Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Zhejiang Jingxin Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  18. 6.3.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  19. 6.4 Xiamen LP Pharmaceutical
  20. 6.4.1 Xiamen LP Pharmaceutical Company Information
  21. 6.4.2 Xiamen LP Pharmaceutical Business Overview
  22. 6.4.3 Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Xiamen LP Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  24. 6.4.5 Xiamen LP Pharmaceutical Recent Developments
  25. 6.5 Macleods Pharmaceuticals Ltd
  26. 6.5.1 Macleods Pharmaceuticals Ltd Company Information
  27. 6.5.2 Macleods Pharmaceuticals Ltd Business Overview
  28. 6.5.3 Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Macleods Pharmaceuticals Ltd Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  30. 6.5.5 Macleods Pharmaceuticals Ltd Recent Developments
  31. 6.6 Cspc Ouyi Pharmaceutical
  32. 6.6.1 Cspc Ouyi Pharmaceutical Company Information
  33. 6.6.2 Cspc Ouyi Pharmaceutical Business Overview
  34. 6.6.3 Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cspc Ouyi Pharmaceutical Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  36. 6.6.5 Cspc Ouyi Pharmaceutical Recent Developments
  37. 6.7 Boehringer Ingelheim International GmbH
  38. 6.7.1 Boehringer Ingelheim International GmbH Company Information
  39. 6.7.2 Boehringer Ingelheim International GmbH Business Overview
  40. 6.7.3 Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Boehringer Ingelheim International GmbH Pramipexole Hydrochloride Extended Release Tablets Product Portfolio
  42. 6.7.5 Boehringer Ingelheim International GmbH Recent Developments
7 North America
  1. 7.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  2. 7.2 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  3. 7.2.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026)
  4. 7.2.2 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032)
  5. 7.2.3 North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032)
  6. 7.3 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  7. 7.3.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026)
  8. 7.3.2 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032)
  9. 7.3.3 North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032)
  10. 7.4 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country
  11. 7.4.1 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  13. 7.4.3 North America Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032)
  14. 7.4.4 North America Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  2. 8.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  3. 8.2.1 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032)
  6. 8.3 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  7. 8.3.1 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032)
  10. 8.4 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country
  11. 8.4.1 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  2. 9.2 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  3. 9.2.1 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026)
  4. 9.2.2 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032)
  5. 9.2.3 China Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032)
  6. 9.3 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  7. 9.3.1 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026)
  8. 9.3.2 China Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032)
  9. 9.3.3 China Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  2. 10.2 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  3. 10.2.1 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032)
  6. 10.3 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  7. 10.3.1 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032)
  10. 10.4 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country
  11. 10.4.1 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pramipexole Hydrochloride Extended Release Tablets Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst